Waystar Holding Corp. (NASDAQ:WAY - Get Free Report) CEO Matthew Hawkins sold 22,462 shares of the company's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $25.04, for a total transaction of $562,448.48. Following the completion of the sale, the chief executive officer owned 1,835,081 shares of the company's stock, valued at approximately $45,950,428.24. This represents a 1.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Waystar Trading Up 2.2%
WAY stock traded up $0.54 during midday trading on Thursday, hitting $25.08. 2,301,045 shares of the company's stock were exchanged, compared to its average volume of 2,704,600. The stock's fifty day moving average price is $21.42 and its 200-day moving average price is $22.80. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.85 and a current ratio of 1.85. The company has a market cap of $4.81 billion, a PE ratio of 35.83, a price-to-earnings-growth ratio of 0.95 and a beta of 0.06. Waystar Holding Corp. has a one year low of $17.26 and a one year high of $41.47.
Waystar (NASDAQ:WAY - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03. The company had revenue of $319.67 million during the quarter, compared to the consensus estimate of $316.21 million. Waystar had a return on equity of 7.03% and a net margin of 11.18%.The company's revenue for the quarter was up 18.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.36 earnings per share. Research analysts predict that Waystar Holding Corp. will post 1.47 earnings per share for the current fiscal year.
Institutional Trading of Waystar
Several institutional investors and hedge funds have recently added to or reduced their stakes in WAY. Clarkston Capital Partners LLC acquired a new stake in shares of Waystar in the first quarter valued at approximately $22,917,000. Hsbc Holdings PLC bought a new position in shares of Waystar during the 1st quarter worth approximately $5,625,000. Renaissance Capital LLC acquired a new position in shares of Waystar during the 4th quarter worth approximately $2,273,000. Advisors Preferred LLC bought a new stake in Waystar in the 4th quarter valued at $3,975,000. Finally, Dimensional Fund Advisors LP raised its stake in Waystar by 73.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,046,396 shares of the company's stock valued at $49,329,000 after acquiring an additional 868,853 shares during the period.
Wall Street Analyst Weigh In
Several analysts have commented on the stock. Wolfe Research upgraded shares of Waystar to an "outperform" rating in a report on Thursday. Citigroup reissued a "buy" rating on shares of Waystar in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $39.00 price objective on shares of Waystar in a report on Friday, July 31st. Truist Financial lowered their price objective on shares of Waystar from $38.00 to $33.00 and set a "buy" rating on the stock in a report on Thursday. Finally, KeyCorp reissued an "overweight" rating on shares of Waystar in a research report on Friday, July 31st. Three equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $35.00.
Check Out Our Latest Stock Report on Waystar
Waystar Company Profile
(
Get Free Report)
Waystar NASDAQ: WAY is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company's unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar's offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Waystar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waystar wasn't on the list.
While Waystar currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.